Company Long-Term Loans and Borrowings: Dianthus Pharma (DNTH)
The Dianthus Therapeutics (DNTH) price chart demonstrates the dynamics of an asset that remains insulated from geopolitical influence due to the specific nature of its scientific research. The current indicator stands at 0.00. The business relies on the development of targeted therapies to combat severe autoimmune disorders, ensuring a stable revenue stream through lifelong treatment. Additionally, Dianthus Therapeutics is developing advanced complement inhibitors by implementing convenient subcutaneous drug delivery methods.
Dianthus Pharma (DNTH) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Dianthus Therapeutics|DNTH - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Dianthus Corp|DNTH - Company Debts|Debt to Book Value Dianthus Therapeutics|DNTH - Company Long-Term Debt|Company Current Liabilities Dianthus Therapeutics|Quick Ratio dianthustx.com
- earnings and multiples data:
Analysis of all company metrics:DNTH - dianthustx.com
This indicator aggregates all creditor obligations and bonds with maturities exceeding one year, determining long-term capital stability. The stability of the business's long-term borrowings allows for an assessment of the financial cushion of Dianthus Therapeutics (DNTH), which is critical when delegating antibody production to external contractors and relying on the reliability of partner supply chains.
Competitors of Dianthus Therapeutics (DNTH)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Pharvaris (PHVS) - Company Long-Term Debt|Company Long-Term Liabilities AbCellera Bio|Company Long-Term Liabilities TRML|Company Long-Term Debts Precigen Corp|Company Long-Term Debt Pharming Group N.V. (PHAR)|nektar.com - Company Long-Term Indebtedness|Company Long-Term Debts UPB (Upstream Bio)|Zenas Bio (ZBIO) - Long-Term Debt|Immunome Corp - Company Long-Term Debts|GOSS (Gossamer Bio Corp.) - Company Long-Term Indebtedness|KALV: Company Long-Term Debts|SEPN - Long-Term Debt Volume|PVLA (Pieris Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Debts Savara Inc|Company Long-Term Debt Rigel Pharmaceuticals Inc (RIGL)|AnaptysBio Inc. - Company Long-Term Indebtedness|Astria Therapeutics - Company Long-Term Liabilities|Amount of Long-Term Liabilities ENGN (engene.com)|RAPT Therapeutics, Inc. - Company Long-Term Debts|Company Long-Term Loans and Borrowings JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris) - Company Long-Term Liabilities|Kyverna Therapeutics, Inc (KYTX) - Company Long-Term Debts|Company Long-Term Debt Tiziana Life Sciences|cabalettabio.com (CABA) - Long-Term Debt Volume|Company Long-Term Liabilities VTYX (Ventyx Biosciences, Inc.)|THTX (Theratechnologies, Inc.) - Company Long-Term Loans and Borrowings|Avalo Therapeutics Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities ELDN (Eledon Pharmaceuticals, Inc)|Agenus - Company Long-Term Debts|Company Long-Term Loans and Borrowings CLYM (climbbio.com)|ZURA: Company Long-Term Debts|Long-Term Debt aTyr Pharma Inc (ATYR)|Company Long-Term Debt Adagene Inc|IMA: Company Long-Term Loans and Borrowings|Company Long-Term Debts STTK|Company Long-Term Debts equilliumbio.com (EQ)|Company Long-Term Debt Connect Biopharma Holdings Limited CNTB|IMUX (Immunic Therapeutics) - Long-Term Liabilities|Atara Biotherapeutics Inc - Company Long-Term Debts|Long-Term Debt InflaRx N.V.|XFOR (X4 Pharmaceuticals) - Company Long-Term Liabilities|Adicet Bio, Inc. (ACET) - Company Long-Term Debts|Company Long-Term Liabilities CELU|INMB (INmune Bio Inc) - Amount of Long-Term Liabilities|Company Long-Term Debts BRNS|Long-Term Debt Volume Kezar Life Sciences Inc|Company Long-Term Debts SABS (SAB Biotherapeutics)|AKTX - Company Long-Term Liabilities|ENLV - Company Long-Term Debt|Long-Term Debt Volume Q32 Bio Inc. QTTB|GOVX: Company Long-Term Debts|Company Long-Term Indebtedness EDSA|Company Long-Term Debt iBio, Inc.|Company Long-Term Indebtedness CARM (Carisma Tx)|Company Long-Term Liabilities XTLB (XTL Biopharmaceuticals Ltd.)|Amount of Long-Term Liabilities BOLT|Company Long-Term Debts HCWB (HCW Biologics)|Company Long-Term Loans and Borrowings APVO|AIM - Company Long-Term Debt|Long-Term Liabilities ADTX|GRI: Company Long-Term Debts|XORTX Therapeutics Inc - Company Long-Term Loans and Borrowings|HIND (ReShape Lifesciences) - Company Long-Term Debts|Company Long-Term Debts Revelation Biosciences Corp|Company Long-Term Debt Indaptus Therapeutics (INDP)|SCNI (scinai.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt CalciMedica CALI|AFMD - Company Long-Term Liabilities|Allakos Therapeutics - Company Long-Term Debts|HOOK - Company Long-Term Debts|IGMS (igmbio.com) - Company Long-Term Liabilities|iteostherapeutics.com - Company Long-Term Loans and Borrowings|OCEA (Ocean Biomedical) - Company Long-Term Debts|TC BioPharm (Holdings) Plc (TCBP) - Long-Term Debt Volume|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)